37 related articles for article (PubMed ID: 21426805)
1. The ras-related protein RAB22A interacts with hypoxia-inducible factor 1-alpha (HIF-1α) in MDA-MB-231 breast cancer cells in hypoxia.
Papanikolaou NA; Kakavoulia M; Ladias C; Papavassiliou AG
Mol Biol Rep; 2024 Apr; 51(1):564. PubMed ID: 38647725
[TBL] [Abstract][Full Text] [Related]
2. [Metformin suppresses hypoxia-inducible factor-1
Shao S; Bai W; Zhou P; Luo M; Zhao X; Lei J
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):428-436. PubMed ID: 38597433
[TBL] [Abstract][Full Text] [Related]
3. Lactate in breast cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome.
Liu Y; Suhail Y; Novin A; Afzal J; Pant A; Kshitiz
Hum Cell; 2024 May; 37(3):768-781. PubMed ID: 38478356
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment.
Zhi S; Chen C; Huang H; Zhang Z; Zeng F; Zhang S
Front Immunol; 2024; 15():1370800. PubMed ID: 38799423
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α.
Tosatto A; Sommaggio R; Kummerow C; Bentham RB; Blacker TS; Berecz T; Duchen MR; Rosato A; Bogeski I; Szabadkai G; Rizzuto R; Mammucari C
EMBO Mol Med; 2016 May; 8(5):569-85. PubMed ID: 27138568
[TBL] [Abstract][Full Text] [Related]
6. Activation of RhoA/ROCK2 signaling by hypoxia-inducible factor 1α in promoting tumor growth and metastasis in human colon cancer.
Du K; Wang P; Liu J; Ren J; Zheng G; Li S; Chen L; Hou W; Hashida H; Feng F; Zheng J
J Gastrointest Oncol; 2024 Feb; 15(1):237-249. PubMed ID: 38482232
[TBL] [Abstract][Full Text] [Related]
7. The interaction between LYVE-1 with hyaluronan on the cell surface may play a role in the diversity of adhesion to cancer cells.
Du Y; Liu H; He Y; Liu Y; Yang C; Zhou M; Wang W; Cui L; Hu J; Gao F
PLoS One; 2013; 8(5):e63463. PubMed ID: 23717428
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor 1 and breast cancer metastasis.
Liu ZJ; Semenza GL; Zhang HF
J Zhejiang Univ Sci B; 2015 Jan; 16(1):32-43. PubMed ID: 25559953
[TBL] [Abstract][Full Text] [Related]
9. Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy.
Liu Q; Guan C; Liu C; Li H; Wu J; Sun C
Biomed Pharmacother; 2022 Dec; 156():113861. PubMed ID: 36228375
[TBL] [Abstract][Full Text] [Related]
10. [Impact of hypoxia-inducible factor-1 on tumor invasion and metastasis in breast cancer].
Wang F; Chang MM; Zhao J; Jiang LL; Shi YH
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):99-103. PubMed ID: 21426805
[TBL] [Abstract][Full Text] [Related]
11. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
[TBL] [Abstract][Full Text] [Related]
12. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.
Shah T; Krishnamachary B; Wildes F; Mironchik Y; Kakkad SM; Jacob D; Artemov D; Bhujwalla ZM
Oncotarget; 2015 Sep; 6(29):28104-19. PubMed ID: 26305551
[TBL] [Abstract][Full Text] [Related]
13. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor.
Sun L; Liu Y; Lin S; Shang J; Liu J; Li J; Yuan S; Zhang L
Acta Oncol; 2013 May; 52(4):842-51. PubMed ID: 23409769
[TBL] [Abstract][Full Text] [Related]
14. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
15. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
